Prescribing patterns of antidepressants in Europe: Results from the Factors Influencing Depression Endpoints Research (FINDER) study
Michael Bauer, André Tylee(King's College London), Deborah Quail(Eli Lilly (United Kingdom)), Koen Demyttenaere(University Psychiatric Hospital), Catherine Reed(Eli Lilly (United States)), David Pérahia(École Normale Supérieure Paris-Saclay), Ángel L. Montejo(Universidad de Salamanca), Luigi Grassi(University of Ferrara), A Garcia-Cebrian(Eli Lilly (United Kingdom)), N. Dantchev, Brigitta U. Monz(Boehringer Ingelheim (Germany))
Cited by 186
Related Papers
Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions
|World Psychiatry|2023|751
Anxious and non-anxious major depressive disorder in the World Health Organization World Mental Health Surveys
|Epidemiology and Psychiatric Sciences|2015|626
The expanding role of primary care in cancer control
|The Lancet Oncology|2015|544
The associations between non-suicidal self-injury and first onset suicidal thoughts and behaviors
|Journal of Affective Disorders|2018|436
The identification, assessment and management of difficult-to-treat depression: An international consensus statement
|Journal of Affective Disorders|2020|277